An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

Stopped The Sponsor has decided to focus their resources on other areas of therapy.

Conditions

• Duchenne Muscular Dystrophy

Interventions

• DRUG: Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

Sponsor

Rare Disease Research, LLC

Collaborators

• [object Object]